Jun Zhu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Men Who Have Sex With Men

Top Venues

International journal of molecular sciences

NeuroImmune pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Catya Jiménez-Torres, Katherine D Porter, Jamison A Hastie, Charles Adeniran, Omar Moukha-Chafiq, Theresa H Nguyen, Subramaniam Ananthan, Corinne E Augelli-Szafran, Chang-Guo Zhan, Jun Zhu
Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter. International journal of molecular sciences 25 (14) (2024)
Ana Catya Jiménez-Torres, Katherine D Porter, Jamison A Hastie, Charles Adeniran, Omar Moukha-Chafiq, Theresa H Nguyen, Subramaniam Ananthan, Corinne E Augelli-Szafran, Chang-Guo Zhan, Jun Zhu
Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter. International journal of molecular sciences 25 (14) (2024)
Ana Catya Jiménez-Torres, Katherine D Porter, Jamison A Hastie, Charles Adeniran, Omar Moukha-Chafiq, Theresa H Nguyen, Subramaniam Ananthan, Corinne E Augelli-Szafran, Chang-Guo Zhan, Jun Zhu
Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter. International journal of molecular sciences 25 (14) (2024)
Ana Catya Jiménez-Torres, Katherine D Porter, Jamison A Hastie, Charles Adeniran, Omar Moukha-Chafiq, Theresa H Nguyen, Subramaniam Ananthan, Corinne E Augelli-Szafran, Chang-Guo Zhan, Jun Zhu
Effects of SRI-32743, a Novel Quinazoline Structure-Based Compound, on HIV-1 Tat and Cocaine Interaction with Norepinephrine Transporter. International journal of molecular sciences 25 (14) (2024)
Haylee R Hammond, Shainnel O Eans, Thomas J Cirino, Subramaniam Ananthan, Ana Catya Jimenez-Torres, Jun Zhu, Jay P McLaughlin
SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice. NeuroImmune pharmacology and therapeutics 3 (1) (2023)
Haylee R Hammond, Shainnel O Eans, Thomas J Cirino, Subramaniam Ananthan, Ana Catya Jimenez-Torres, Jun Zhu, Jay P McLaughlin
SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice. NeuroImmune pharmacology and therapeutics 3 (1) (2023)
Haylee R Hammond, Shainnel O Eans, Thomas J Cirino, Subramaniam Ananthan, Ana Catya Jimenez-Torres, Jun Zhu, Jay P McLaughlin
SRI-30827, a novel allosteric modulator of the dopamine transporter, alleviates HIV-1 Tat-induced potentiation of cocaine conditioned place preference in mice. NeuroImmune pharmacology and therapeutics 3 (1) (2023)
Matthew J Strauss, Katherine D Porter, Pamela M Quizon, Sarah E Davis, Steven Lin, Yaxia Yuan, Gustavo A Martinez-Muniz, Wei-Lun Sun, Chang-Guo Zhan, Jun Zhu
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. PloS one 17 (9) (2022)